MPO and hepatocellular carcinoma: Our main findings are that both MPO-DNA and H3Cit-DNA are elevated in plasma from patients with end-stage liver cirrhosis (Child–Pugh B and C, or MELD > 14), whereas Child–Pugh A patients (and HCC patients without cirrhosis) with preserved liver function have levels similar to those of healthy controls.